1 idea from this batch

AstraZeneca's heart drug flops in trials — short the failed-drug fallout

When a major drug trial fails, it often triggers a panic sell-off as investors rush to the exits. This selling pressure can cause the stock to fall sharply in a short period as the market re-evaluates the company's future earnings potential